Immune gene expression in head and neck squamous cell carcinoma patients

Lecerf, Charlotte; Kamal, Maud; Vacher, Sophie; Chemlali, Walid; Schnitzler, Anne; Morel, Claire; Dubot, Coraline; Jeannot, Emmanuelle; Meseure, Didier; Klijanienko, Jerzy; Mariani, Odette; Borcoman, Édith; Calugaru, Valentin; Badois, Nathalie; Chillès, A.; Lesnik, Maria; Krhili, S.; Choussy, O.; Hoffmann, Caroline; Piaggio, Eliane; Bièche, Ivan; Le Tourneau, Christophe

doi:10.1016/j.ejca.2019.08.028

Public

Immune gene expression in head and neck squamous cell carcinoma patients

Published in European Journal of Cancer • Oct 5, 2019

Authors:

Charlotte Lecerf

Maud Kamal

Sophie Vacher

Abstract

BACKGROUND: Nivolumab and pembrolizumab targeting programmed cell death protein 1 (PD-1) have recently been approved among patients with recurrent and/or metastatic head and neck squamous cell carcinoma (HNSCC) who failed platinum therapy. We aimed to evaluate the prognostic value of selected immune...

Subject

Immune system

Medicine

Head and neck squamous-cell carcinoma

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!